Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Martin-Kleiner

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 17, 2002
The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cellsI Martin-Kleiner
Immunopharmacology and Immunotoxicology|March 1, 1993
Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonistI Martin-Kleiner, J Gabrilovac
Immunopharmacology and Immunotoxicology|February 1, 1996
Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assayI Martin-Kleiner, J Gabrilovac
International Journal of Immunopathology and Pharmacology|June 5, 2003
The effect of δ-opioid agonists on intracellular calcium level in MOLT-4 T-cell lineI Martin - Kleiner, J Gabrilovac
International Journal of Immunopharmacology|May 7, 1999
The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell lineI Martin-Kleiner, J M Bidlack
International Immunopharmacology|May 23, 2001
Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activityI Martin-Kleiner, J M Bidlack
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1992
Regulation of NK cell activity and the level of the intracellular cAMP in human peripheral blood lymphocytes by Met-enkephalinI Martin-Kleiner, M Osmak, J Gabrilovac
Immunopharmacology and Immunotoxicology|September 26, 2006
PMA and doxorubicin decrease viability, MTT activity and expression of CD10 marker on NALM-1 leukemic cellsI Martin-Kleiner, I Svoboda-Beusan, J Gabrilovac
Annals of the New York Academy of Sciences|April 15, 1992
Interaction of Leu-enkephalin and alpha-interferon in modulation of NK-activity of human peripheral blood lymphocytesJ Gabrilovac, I Martin-Kleiner, M Ikić-Sutlić, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1989
In vivo and in vitro modulation of NK and ADCC activities of mouse spleen cells by peptidoglycan monomer (PGM)J Gabrilovac, J Tomasić, M Boranić, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 17, 2002
The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cellsI Martin-Kleiner
Immunopharmacology and Immunotoxicology|March 1, 1993
Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonistI Martin-Kleiner, J Gabrilovac
Immunopharmacology and Immunotoxicology|February 1, 1996
Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assayI Martin-Kleiner, J Gabrilovac
International Journal of Immunopathology and Pharmacology|June 5, 2003
The effect of δ-opioid agonists on intracellular calcium level in MOLT-4 T-cell lineI Martin - Kleiner, J Gabrilovac
International Journal of Immunopharmacology|May 7, 1999
The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell lineI Martin-Kleiner, J M Bidlack
International Immunopharmacology|May 23, 2001
Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activityI Martin-Kleiner, J M Bidlack
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1992
Regulation of NK cell activity and the level of the intracellular cAMP in human peripheral blood lymphocytes by Met-enkephalinI Martin-Kleiner, M Osmak, J Gabrilovac
Immunopharmacology and Immunotoxicology|September 26, 2006
PMA and doxorubicin decrease viability, MTT activity and expression of CD10 marker on NALM-1 leukemic cellsI Martin-Kleiner, I Svoboda-Beusan, J Gabrilovac
Annals of the New York Academy of Sciences|April 15, 1992
Interaction of Leu-enkephalin and alpha-interferon in modulation of NK-activity of human peripheral blood lymphocytesJ Gabrilovac, I Martin-Kleiner, M Ikić-Sutlić, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1989
In vivo and in vitro modulation of NK and ADCC activities of mouse spleen cells by peptidoglycan monomer (PGM)J Gabrilovac, J Tomasić, M Boranić, et al.
Pageof 2